DEL BOCCIO, PIERO
 Distribuzione geografica
Continente #
NA - Nord America 4.811
EU - Europa 3.871
AS - Asia 3.056
SA - Sud America 384
AF - Africa 45
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 7
Totale 12.188
Nazione #
US - Stati Uniti d'America 4.685
SG - Singapore 1.281
IT - Italia 1.061
CN - Cina 995
IE - Irlanda 606
SE - Svezia 383
DE - Germania 382
GB - Regno Unito 358
UA - Ucraina 351
BR - Brasile 322
TR - Turchia 293
FR - Francia 201
FI - Finlandia 178
VN - Vietnam 168
IN - India 137
RU - Federazione Russa 93
CA - Canada 74
PL - Polonia 57
HK - Hong Kong 43
MX - Messico 43
NL - Olanda 42
CZ - Repubblica Ceca 34
JP - Giappone 33
ES - Italia 31
ZA - Sudafrica 30
AR - Argentina 28
BE - Belgio 25
AT - Austria 24
LT - Lituania 17
BD - Bangladesh 16
IQ - Iraq 13
KR - Corea 13
AE - Emirati Arabi Uniti 12
AU - Australia 12
ID - Indonesia 10
VE - Venezuela 10
CL - Cile 5
MA - Marocco 5
PK - Pakistan 5
PY - Paraguay 5
UZ - Uzbekistan 5
BG - Bulgaria 4
CO - Colombia 4
EU - Europa 4
IR - Iran 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
AM - Armenia 3
BO - Bolivia 3
CH - Svizzera 3
DK - Danimarca 3
EC - Ecuador 3
EG - Egitto 3
GR - Grecia 3
JO - Giordania 3
MY - Malesia 3
PE - Perù 3
AZ - Azerbaigian 2
HN - Honduras 2
IL - Israele 2
KE - Kenya 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
RO - Romania 2
RS - Serbia 2
SA - Arabia Saudita 2
SN - Senegal 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BS - Bahamas 1
BW - Botswana 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PW - Palau 1
SI - Slovenia 1
TJ - Tagikistan 1
TW - Taiwan 1
Totale 12.188
Città #
Singapore 940
Chandler 672
Dublin 597
Jacksonville 426
Beijing 340
Ashburn 332
Dallas 326
Chieti 233
Southend 216
Munich 204
Princeton 199
Los Angeles 163
The Dalles 159
Santa Clara 158
Izmir 153
Pescara 148
Nanjing 143
Dearborn 138
New York 116
Ann Arbor 89
Altamura 88
Wilmington 88
Boardman 76
Helsinki 69
Cambridge 64
Rome 64
Nanchang 57
Tongling 57
Ho Chi Minh City 54
São Paulo 49
Buffalo 44
Woodbridge 43
Hong Kong 41
Montreal 35
Redondo Beach 35
Warsaw 35
Denver 33
Tokyo 33
Turku 33
Hanoi 29
Kunming 27
Hefei 25
Brussels 24
Shenyang 24
Poplar 23
Brno 22
Brooklyn 22
Dong Ket 22
London 22
Nuremberg 21
Seattle 21
Johannesburg 20
Toronto 20
Frankfurt am Main 19
Hangzhou 19
Washington 19
Amsterdam 18
Guangzhou 18
Hebei 18
San Mateo 18
Tianjin 18
Atlanta 17
Phoenix 17
Stockholm 17
Mexico City 16
Orem 16
Augusta 15
Houston 15
Jiaxing 15
Kraków 15
Vienna 15
Milan 14
Chennai 13
Chicago 13
L'aquila 13
Lappeenranta 13
Ankara 12
Düsseldorf 12
Teramo 12
Boston 11
Grevenbroich 11
Norwalk 11
Jinan 10
Manchester 10
Olomouc 10
Camerino 9
Charlotte 9
Redwood City 9
Seoul 9
Bologna 8
Changsha 8
Naples 8
Pune 8
San Francisco 8
Sydney 8
Torre de' Passeri 8
Belo Horizonte 7
Falls Church 7
Leawood 7
L’Aquila 7
Totale 7.662
Nome #
Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients 328
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis 188
Serum Lipidomic study reveals potential early biomarkers for predicting response to chemoradiotherapy in advanced rectal cancer: A pilot study 163
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid 161
Gold nanoparticles as scaffolds for poor water soluble and difficult to vehiculate antiparkinson codrugs 161
Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis 155
A computational platform for MALDI-TOF mass spectrometry data: Application to serum and plasma samples 152
A lipidomic approach to the study of human CD4(+) T lymphocytes in multiple sclerosis. 152
Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation 149
Advances in Lipidomics for Cancer Biomarkers Discovery 148
Integration of metabolomics and proteomics in multiple sclerosis: from biomarkers discovery to personalized medicine 147
Cleavage of cystatin C is not associated with multiple sclerosis 147
Neurodegenerative diseases as proteinopathies-driven immune disorders 143
Proteomic profiling of coronary thrombus in acute myocardial infarction 141
Reappraisal of the clinical pharmacology of low-dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action 140
A hyphenated microLC-Q-TOF-MS platform for exosomal lipidomics investigations: application to RCC urinary exosomes 140
Diabetic macroangiopathy: Pathogenetic insights and novel therapeutic approaches with focus on high glucose-mediated vascular damage 139
Visible Photostability of Ruthenium and Platinum Phthalocyanines in Water and in the presence of Organic Substrates 137
Proteomics characterization of protein adsorption onto hemodialysis membranes 136
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 136
Extracellular vesicles and their potential use in monitoring cancer progression and therapy: The contribution of proteomics 135
Development of a Rapid Mass Spectrometric Determination of AMP and Cyclic AMP for PDE3 Activity Study: Application and Computational Analysis for Evaluating the Effect of a Novel 2-oxo-1,2-dihydropyridine-3-carbonitrile Derivative as PDE-3 Inhibitor 135
Beta2-microglobulin causes abnormal phosphatidylserine exposure in human red blood cells. 134
Analytical assessment of MALDI-TOF Imaging Mass Spectrometry on thin histological samples. An insight in proteome investigation. 132
Metabolomic Signature in Sera of Multiple Sclerosis Patients during Pregnancy 132
Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation 128
UNRAVELING THE MOLECULAR REPERTOIRE OF TEARS AS A SOURCE OF BIOMARKERS: BEYOND OCULAR DISEASES 128
A proteomic approach for the characterization of C677T mutation of the human gene methylenetetrahydrofolate reductase. 125
BNT162b2 mRNA vaccination leads to long-term protection from COVID-19 disease 124
Tear Film Steroid Profiling in Dry Eye Disease by Liquid Chromatography Tandem Mass Spectrometry 121
Cytotoxic and genotoxic effects of composite resins on cultured human gingival fibroblasts 121
Independent component analysis for the extraction of reliable protein signal profiles from MALDI-TOF mass spectra 120
Comparative proteome profiling of breast tumor cell lines by gel electrophoresis and mass spectrometry reveals an epithelial mesenchymal transition associated protein signature. 120
LIMPIC: a computational method for the separation of protein MALDI-TOF-MS signals from noise 119
Glutathione transferases from Anguilla anguilla liver: identification, cloning and functional characterization. 119
AFFINITY AND SPECIFICITY OF ANTI-GM1 ANTIBODIES IN THE EXPERIMENTAL AXONAL MODEL OF GUILLAIN-BARRE SYNDROME 119
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 118
An Italian Innovative Small-Scale Approach to Promote the Conscious Consumption of Healthy Food 118
ESI-MS in the study of the activity of alpha-chymotrypsin in aqueous surfactant media. 117
Differential post-translational modifications of transthyretin in Alzheimer's disease: a study of the cerebral spinal fluid. 117
Differential protein expression in tears of patients with primary open angle and pseudoexfoliative glaucoma 117
Proteomics of thyroid fine-needle apiration: a promising approach for protein biomarker discovery 117
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 116
Inhibition of de novo ceramide biosynthesis affects aging phenotype in an in vitro model of neuronal senescence 116
CD19.CAR-T cell-derived extracellular vesicles express CAR and kill leukemic cells, contributing to antineoplastic therapy 115
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 114
Stereoselective double reduction of 3-methyl-2-cyclohexenone by use of palladium and platinum nanoparticles in tandem with alcohol dehydrogenase 113
Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway 113
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 112
Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin. 110
extracellular vescicles as signaling mediators and disease biomarkers across biological barriers 110
Flow Cytometry Analysis of Circulating Extracellular Vesicle Subtypes from Fresh Peripheral Blood Samples 109
DIFFERENTIAL CEREBRO SPINAL FLUID PROTEOME INVESTIGATION OF LEBER HEREDITARY OPTIC NEUROPATHY (LHON) AND MULTIPLE SCLEROSIS. 108
Protein expression profiling of Proteus mirabilis under chemical stress condition: A proteomic investigation without genome 108
Basophil Activation Test with Different Polyethylene Glycols in Patients with Suspected PEG Hypersensitivity Reactions 108
Lo sviluppo di un confronto matematico per analisi differenziali di proteomica: applicazione ai profili MALDI-TOF-MS lineare. 107
TLC-MALDI-Imaging approach for lipidomics studies in cerebrospinal fluid reveals low levels of sphingomyelin in multiple sclerosis patients 107
Oxidative degradation of cardiotoxic anticancer anthracyclines to phthalic acids. Novel function or ferrylmyoglobin. 106
Validation of the GSP®/DELFIA® Anti-SARS-CoV-2 IgG Kit Using Dried Blood Samples for High-Throughput Serosurveillance and Standardized Quantitative Measurement of Anti-Spike S1 IgG Antibody Responses Post-Vaccination 105
Liquid chromatography-tandem mass spectrometry analysis of oleuropein and its metabolite hydroxytyrosol in rat plasma and urine after oral administration. 104
Proteomic investigation in the detection of the illicit treatment of calves with growth-promoting agents. 104
A proteomic approach to paclitaxel chemoresistance in ovarian cancer cell lines. 104
Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation" 104
Clinical pharmacology of cyclooxygenase inhibition and pharmacodynamic interaction with aspirin by floctafenine in Thai healthy subjects. 103
Characterization of oxidation end product of plasma albumin 'in vivo'. 103
Targeted metabolomics detects a putatively diagnostic signature in plasma and dried blood spots from head and neck paraganglioma patients 102
Monospecific high-affinity and complement activating anti-GM1 antibodies are determinants in experimental axonal neuropathy 102
Homo sapiens proteomics: clinical perspectives 101
Electrophoretic separations of cerebrospinal fluid proteins in clinical investigations. 101
Transitions of serum albumin in patients with glomerulosclerosis 'in vivo' characterization by electrophoretic titration curves. 98
Resveratrol downregulates Akt/GSK and ERK signalling pathways in OVCAR-3 ovarian cancer cells. 98
Shotgun proteomics reveals specific modulated protein patterns in tears of patients with primary open angle glaucoma naïve to therapy. 98
OXIDATIVE MODIFICATIONS OF CEREBRAL TRANSTHYRETIN ARE ASSOCIATED WITH MULTIPLE SCLEROSIS 98
Pre-analytical factors in clinical proteomics investigations: Impact of ex vivo protein modifications for multiple sclerosis biomarker discovery 98
Repetitive Fragmentation Products of Albumin and {alpha}1-Antitrypsin in Glomerular Diseases Associated with Nephrotic Syndrome. 97
Proteomic analysis of protein adsorption onto haemodialysis membranes 96
Quantitative analysis of caffeic acid phenethyl ester in crude propolis by liquid chromatography-electrospray ionization mass spectrometry. 95
Mass spectrometry based metabonomics of the cerebrospinalfluid highlights a correlation between polar lipids and carnitines levels in multiple sclerosis patients. 95
Breast cancer in the era of integrating "Omics" approaches 94
Fast LC–MS/MS screening method for the evaluation of drugs, illicit drugs, and other compounds in biological matrices 93
High-resolution 2-DE for resolving proteins, protein adducts and complexes in plasma. 92
Improving protein identification from linear MALDI-TOF spectra: validation of an automated tool for signal denoising and peak identification 91
Proteomic investigations on differential post-translational modification of transthyretin in multiple sclerosis. 91
Multi-omics staging of locally advanced rectal cancer predicts treatment response: a pilot study 90
In vitro and in vivo lipidomics as a tool for probiotics evaluation 90
Synthesis and Biological Evaluation of Novel Cinnamic Acid-Based Antimicrobials 90
Biomarker investigations in neurodegenerative diseases 89
Analytical Evaluation of the Ideal Strategy for High-Throughput Flow Injection Analysis by Tandem Mass Spectrometry in Routine Newborn Screening 88
Extracellular Vesicles in Regenerative Processes Associated with Muscle Injury Recovery of Professional Athletes Undergoing Sub Maximal Strength Rehabilitation 86
Proteins and protein fragments in nephrotic syndrome: Clusters, specificity and mechanisms 86
Impact of Maternal Lifestyle and Dietary Habits during Pregnancy on Newborn Metabolic Profile 85
Anti-Obesity and Anti-Inflammatory Effects of Novel Carvacrol Derivatives on 3T3-L1 and WJ-MSCs Cells 85
Ozone effect on the inflammatory and proteomic profile of human macrophages and airway epithelial cells 83
Chronic Oleoylethanolamide Treatment Decreases Hepatic Triacylglycerol Level in Rat Liver by a PPARγ/SREBP-Mediated Suppression of Fatty Acid and Triacylglycerol Synthesis 82
FACS-Proteomics strategy toward extracellular vesicles single-phenotype characterization in biological fluids: exploring the role of leukocyte-derived EVs in multiple sclerosis 82
Proteomic Investigation of the Role of Nucleostemin in Nucleophosmin-Mutated OCI-AML 3 Cell Line 81
Exploring the Immunomodulatory Potential of Pancreatic Cancer-Derived Extracellular Vesicles through Proteomic and Functional Analyses 80
Empagliflozin inhibits excessive autophagy through the AMPK/GSK3β signaling pathway in diabetic cardiomyopathy 78
Simulated hyperglycemia impairs insulin signaling in endothelial cells through a hyperosmolar mechanism 78
Picture of the Favourable Immune Profile Induced by Anti-SARS-CoV-2 Vaccination 78
Totale 11.549
Categoria #
all - tutte 51.118
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.118


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021439 0 0 0 0 0 127 24 15 109 69 40 55
2021/2022538 6 12 11 88 29 21 12 34 83 30 58 154
2022/20231.874 136 268 117 208 206 352 100 129 240 31 54 33
2023/20241.072 69 56 71 34 42 404 180 45 17 19 6 129
2024/20252.916 136 469 437 80 84 134 231 153 305 165 332 390
2025/20262.756 558 219 567 714 553 145 0 0 0 0 0 0
Totale 12.759